Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods-Reference-Cited by-同舟云学术

Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods

Published:2009-10-20 Issue:3 Volume:97 Page:311-322
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Karayan-Tapon Lucie,Quillien Véronique,Guilhot Joëlle,Wager Michel,Fromont Gaëlle,Saikali Stephan,Etcheverry Amandine,Hamlat Abderrahmane,Loussouarn Delphine,Campion Loïc,Campone Mario,Vallette François-Marie,Gratas-Rabbia-Ré Catherine

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Clinical Neurology,Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-009-0031-1.pdf

Reference47 articles.

1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996

2. Drablos F, Feyzi E, Aas PA, Vaagbo CB, Kavli B, Bratlie MS, Pena-Diaz J, Otterlei M, Slupphaug G, Krokan HE (2004) Alkylation damage in DNA and RNA—repair mechanisms and medical significance. DNA Repair (Amst) 3:1389–1407. doi: 10.1016/j.dnarep.2004.05.004

3. Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB, Herman JG (2000) Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343:1350–1354

4. Criniere E, Kaloshi G, Laigle-Donadey F, Lejeune J, Auger N, Benouaich-Amiel A, Everhard S, Mokhtari K, Polivka M, Delattre JY, Hoang-Xuan K, Thillet J et al (2007) MGMT prognostic impact on glioblastoma is dependent on therapeutic modalities. J Neurooncol 83:173–179. doi: 10.1007/s11060-006-9320-0

5. Donson AM, Addo-Yobo SO, Handler MH, Gore L, Foreman NK (2007) MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma. Pediatr Blood Cancer 48:403–407. doi: 10.1002/pbc.20803

Cited by 159 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of radiochemotherapy on peripheral immune response in glioblastoma;Cancer Immunology, Immunotherapy;2024-05-16

2. MGMT in TMZ-based glioma therapy: Multifaceted insights and clinical trial perspectives;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-03

3. Low Expression of A3C and PLP2 Indicating a Favorable Prognosis in Human Gliomas;Cellular and Molecular Biology;2023-07-31

4. Significance of O6-methyl guanine methyltransferase promoter methylation in high grade glioma patients: optimal cutoff point, CpG locus, and genetic assay;Journal of Neuro-Oncology;2023-07-20

5. Association between MGMT Enhancer Methylation and MGMT Promoter Methylation, MGMT Protein Expression, and Overall Survival in Glioblastoma;Cells;2023-06-15